Day One Biopharmaceuticals
PrivateLast Round
Private Placement
Aug 1, 2024
Est. Valuation
$1.45B
Total Funding Raised
$535M
Company Overview
Day One Biopharmaceuticals is a biopharmaceutical company that develops and commercializes targeted therapies for patients of all ages with genetically defined cancers, with a focus on pediatric oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Day One Biopharmaceuticals Comparables
Compare Day One Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SpringWorks Therapeutics | 84% | |
| Erasca | 82% | |
| Black Diamond Therapeutics | 79% |
Day One Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Aug 1, 2024 | ||||
| Follow-on Offering | Jun 12, 2023 | ||||
| Follow-on Offering | Jun 17, 2022 | ||||
| IPO | Jun 1, 2021 | ||||
| Series B | Feb 10, 2021 | ||||
Series A | May 21, 2020 |
Key People
Founding team and executive leadership
Day One Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Private Placement |
| Janus Henderson Group | Series B |
| RA Capital Management | Series B |
| Boxer Capital | Series B |
| Fairmount Funds Management | Private Placement |
| Perceptive Advisors | Series B |
| Braidwell | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2024
$175M raised from Access Biotechnology, Braidwell, and others.
- Jun 12, 2023
$173M raised in follow-on offering.
Day One Biopharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Day One Biopharmaceuticals's valuation, stock price, and market status.
Is Day One Biopharmaceuticals a public or private company?
Day One Biopharmaceuticals is a private company.
What is the current stock price of Day One Biopharmaceuticals?
Day One Biopharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Day One Biopharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Day One Biopharmaceuticals worth (valuation)?
Day One Biopharmaceuticals's valuation is estimated at $1.4B based on funding round data.
Can I buy Day One Biopharmaceuticals stock?
Day One Biopharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Day One Biopharmaceuticals's last funding round?
Day One Biopharmaceuticals's most recent funding round was Private Placement on August 1, 2024.
Who are the main investors in Day One Biopharmaceuticals?
Key investors in Day One Biopharmaceuticals include RA Capital Management.
Will Day One Biopharmaceuticals IPO soon?
No public IPO plans have been announced for Day One Biopharmaceuticals.
How can I track Day One Biopharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Day One Biopharmaceuticals's shares on secondary markets.